Source comparison
Research Peptides for Post-Surgery Recovery: Clinical Comparison
Before selecting a peptide protocol, understand what each compound targets and where the evidence stands. BPC-157 Angiogenesis, VEGF upregulation, collagen deposition Tendon, ligament, deep soft tissue repair 200–500 mcg daily (SC/IM) Multiple animal studies,
This comparison does not assign a generated winner or score.
- Before selecting a peptide protocol, understand what each compound targets and where the evidence stands.
- BPC-157
- Angiogenesis, VEGF upregulation, collagen deposition
- Tendon, ligament, deep soft tissue repair
- 200–500 mcg daily (SC/IM)
- Multiple animal studies, limited human data
- Strongest evidence for musculoskeletal healing; systemic effects even with local administration
- TB-500
- Actin regulation, cell migration, inflammation modulation
- Muscle tears, fascial adhesions, systemic inflammation
- 2–5 mg loading (2–3×/week), 2 mg maintenance (1×/week)
- Animal models, human case reports
- Best anti-adhesion properties; critical for surgeries involving fascia or scar-prone tissues
- GHK-Cu
- Collagen/elastin synthesis, MMP activation, immune modulation
- Skin closure, scar reduction, surface wound healing
- 1–3 mg topical or SC near wound site
- Human clinical trials (cosmetic), animal wound models
- Most reliable for cosmetic outcomes; pairs well with BPC-157 for layered repair
- Ipamorelin + CJC-1295
- Growth hormone secretagogue, IGF-1 elevation
- Systemic recovery, protein synthesis support
- 200–300 mcg each, 1×/day (SC)
- Human trials (aging, muscle wasting)
- Indirect support through GH/IGF-1 axis; slower onset but broader metabolic effects